TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results.

Nigel Bundred et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.